Gin Hwa Biotech Incorporation

NT$50.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:7806Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR —
Div yield 1.91%
ROE 8.77%
Pharmaceutical Preparations
Beta (5Y) —
PE TTM 25.21
TSR TTM (16.49%)
Mkt cap NT$1.613B
ROIC 5.77%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$60
19.19%
64.72%
Hold 9|8|2|4|7
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.85
0.90
0.97
1.03
19.52%
25.22%
25.57%
28.66%
RevenueNT$M
186.7
189.1
199.4
202.7
(2.19%)
1.30%
8.81%
11.48%
Peers (US$48.71M)
Cap (US$)
PE
57.72M
—
46.94M
—
Capital
TTM
5Y
10Y
Leveragex
1.083
0.101
0.080
EBIT/Intx
5.013
0.105
0.098
Own earn%
123.49
(23.99)
(21.65)
Sh yield%
59.90
23.22
29.45
Owners
Insiders/Inst%
9.31
38.12
Short interest%
0.52
SBC / revenue%
3.02
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
17–23
$1 testx
0.1
Incr. ROIC%
5